We are live on ! Find out more
CVA

Ceredex Value Advisors Portfolio holdings

AUM $3.18B
1-Year Est. Return 35.23%
This Fund
S&P 500
This Quarter Est. Return
-8.59%
1 Year Est. Return
+35.23%
3 Year Est. Return
+57.24%
5 Year Est. Return
+45.95%
10 Year Est. Return
AUM
$8.32B
AUM Growth
-$941M
Cap. Flow
-$289M
Cap. Flow %
-3.48%
Top 10 Hldgs %
24.9%
Holding
161
New
33
Increased
36
Reduced
64
Closed
27

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$186M
2
KLAC icon
KLA
KLAC
+$177M
3
ECL icon
Ecolab
ECL
+$163M
4
EXR icon
Extra Space Storage
EXR
+$144M
5
ROK icon
Rockwell Automation
ROK
+$123M

Sector Composition

Rank Sector Weight
1 Industrials 21.17%
2 Financials 15.72%
3 Healthcare 13.67%
4 Technology 13.54%
5 Materials 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARE icon
26
Alexandria Real Estate Equities
ARE
$8.72B
$97.7M 1.17%
+482,850
New +$94.2M
VMC icon
27
Vulcan Materials
VMC
$36.4B
$97.7M 1.17%
531,990
+182,623
+52% +$34.1M
BAX icon
28
Baxter International
BAX
$11.4B
$90.2M 1.08%
+1,159,417
New +$97.1M
XEL icon
29
Xcel Energy
XEL
$49.1B
$89.3M 1.07%
1,228,900
+49,865
+4% +$3.43M
A icon
30
Agilent Technologies
A
$36.8B
$88.3M 1.06%
+667,540
New +$91.9M
AZTA icon
31
Azenta
AZTA
$1.21B
$85.2M 1.02%
1,028,050
+545,702
+113% +$46.8M
FTV icon
32
Fortive
FTV
$18.6B
$84.7M 1.02%
1,843,999
-811,199
-31% -$40.1M
DOV icon
33
Dover
DOV
$28.2B
$83.8M 1.01%
+533,913
New +$87.6M
AEE icon
34
Ameren
AEE
$30.6B
$82.7M 0.99%
881,700
-20,250
-2% -$1.77M
MRVL icon
35
Marvell Technology
MRVL
$175B
$81.1M 0.97%
1,131,100
+753,771
+200% +$54.3M
PGR icon
36
Progressive
PGR
$123B
$79.2M 0.95%
695,186
-1,275,355
-65% -$138M
SWK icon
37
Stanley Black & Decker
SWK
$13.6B
$79.2M 0.95%
566,252
-289,349
-34% -$47.8M
AVY icon
38
Avery Dennison
AVY
$12.1B
$78.7M 0.95%
+452,194
New +$84.1M
ZWS icon
39
Zurn Elkay Water Solutions
ZWS
$7.98B
$78.3M 0.94%
2,212,200
+784,681
+55% +$26.1M
BAC icon
40
Bank of America
BAC
$424B
$77M 0.92%
1,866,924
-1,217,597
-39% -$54.9M
EMN icon
41
Eastman Chemical
EMN
$7.78B
$76.9M 0.92%
+681,683
New +$79.9M
VZ icon
42
Verizon
VZ
$182B
$76.5M 0.92%
1,502,560
-52,211
-3% -$2.77M
HR
43
DELISTED
Healthcare Realty Trust Incorporated
HR
$76.4M 0.92%
+2,780,500
New +$82M
BRKR icon
44
Bruker
BRKR
$8.55B
$76.3M 0.92%
1,186,362
+87,953
+8% +$6.01M
EXC icon
45
Exelon
EXC
$47B
$76.1M 0.92%
+1,598,700
New +$67.7M
COO icon
46
Cooper Companies
COO
$14B
$75.7M 0.91%
724,900
+179,128
+33% +$18M
PH icon
47
Parker-Hannifin
PH
$120B
$75M 0.9%
264,322
-315,894
-54% -$95.3M
EMR icon
48
Emerson Electric
EMR
$76.5B
$72.6M 0.87%
+740,646
New +$70.1M
HUBB icon
49
Hubbell
HUBB
$25.6B
$66.6M 0.8%
362,500
+8,869
+3% +$1.66M
IEX icon
50
IDEX
IEX
$16.4B
$65.6M 0.79%
+342,184
New +$69.4M

Similar funds

Ceredex Value Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Ceredex Value Advisors held 161 positions worth $8.32B, down 10% from $9.26B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ceredex Value Advisors withdrew a net $289M in Q1 2022, closing 27 positions and reducing 64 holdings. Its most notable exit was Marathon Petroleum, an estimated $163M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ceredex Value Advisors opened a new position in Zimmer Biomet worth $198M.

  • Ceredex Value Advisors's largest Q1 2022 buy was Zimmer Biomet: 1,542,133 shares worth $198M.
  • Ceredex Value Advisors added most to KLA in Q1 2022, an estimated $177M increase.
  • Ceredex Value Advisors's biggest Q1 2022 reduction was Baker Hughes, cutting an estimated $239M.
  • Ceredex Value Advisors fully exited Marathon Petroleum in Q1 2022, selling an estimated $163M.
  • Ceredex Value Advisors's ten largest holdings make up 25% of its $8.32B portfolio in Q1 2022.
  • Ceredex Value Advisors opened 33 new positions and closed 27 in Q1 2022.
  • Ceredex Value Advisors's portfolio value fell 10% quarter-over-quarter to $8.32B.

Based on Ceredex Value Advisors's 13F filing for Q1 2022, filed 5 May 2022.